Cerebral Therapeutics rakes in $3 mln Series A
Aurora, Colorado-based Cerebral Therapeutics Inc, a clinical-stage company focused on implanted drug-device combination therapies, has secured $3 million in Series A financing. The investors were Granite Point Capital Management LP and Vivo Capital LLC.
20 June 2018•1 min read
